Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Osteosarcoma
Osteosarcoma is the most common primary malignant tumour of the bone. Osteosarcoma
incidence is bimodal, peaking at 18 and 60 years of age, and is slightly more common in …
incidence is bimodal, peaking at 18 and 60 years of age, and is slightly more common in …
Ewing sarcoma—diagnosis, treatment, clinical challenges and future perspectives
Ewing sarcoma, a highly aggressive bone and soft-tissue cancer, is considered a prime
example of the paradigms of a translocation-positive sarcoma: a genetically rather simple …
example of the paradigms of a translocation-positive sarcoma: a genetically rather simple …
[HTML][HTML] Molecular biology of osteosarcoma
Osteosarcoma (OS) is the most frequent primary bone cancer in children and adolescents
and the third most frequent in adults. Many inherited germline mutations are responsible for …
and the third most frequent in adults. Many inherited germline mutations are responsible for …
[HTML][HTML] Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
PG Casali, N Abecassis, S Bauer, R Biagini, S Bielack… - Annals of …, 2018 - Elsevier
Soft tissue sarcomas (STSs) gather over 80 histological entities, with even more molecular
subsets, characterised by a low to very low incidence in all populations. The majority of …
subsets, characterised by a low to very low incidence in all populations. The majority of …
[HTML][HTML] Targeting molecular mechanisms underlying treatment efficacy and resistance in osteosarcoma: a review of current and future strategies
I Lilienthal, N Herold - International journal of molecular sciences, 2020 - mdpi.com
Osteosarcoma is the most common primary malignant bone tumour in children and
adolescents. Due to micrometastatic spread, radical surgery alone rarely results in cure …
adolescents. Due to micrometastatic spread, radical surgery alone rarely results in cure …
Targeting strategies for bone diseases: signaling pathways and clinical studies
H Xu, W Wang, X Liu, W Huang, C Zhu, Y Xu… - … and Targeted Therapy, 2023 - nature.com
Since the proposal of Paul Ehrlich's magic bullet concept over 100 years ago, tremendous
advances have occurred in targeted therapy. From the initial selective antibody, antitoxin to …
advances have occurred in targeted therapy. From the initial selective antibody, antitoxin to …
Osteosarcoma
BR Eaton, R Schwarz, R Vatner, B Yeh… - Pediatric blood & …, 2021 - Wiley Online Library
Osteosarcoma is a rare tumor that requires complex multidisciplinary management. This
paper reviews the general management and standard radiotherapy guidelines for …
paper reviews the general management and standard radiotherapy guidelines for …
Chondrosarcoma: a clinical review
A Gazendam, S Popovic, N Parasu… - Journal of Clinical …, 2023 - mdpi.com
Chondrosarcomas are a diverse group of malignant cartilaginous matrix-producing
neoplasms. Conventional chondrosarcomas are a continuum of disease based on the …
neoplasms. Conventional chondrosarcomas are a continuum of disease based on the …
Ultra‐rare sarcomas: a consensus paper from the Connective Tissue Oncology Society community of experts on the incidence threshold and the list of entities
S Stacchiotti, AM Frezza, JY Blay, EH Baldini… - Cancer, 2021 - Wiley Online Library
Background Among sarcomas, which are rare cancers, many types are exceedingly rare;
however, a definition of ultra‐rare cancers has not been established. The problem of ultra …
however, a definition of ultra‐rare cancers has not been established. The problem of ultra …
A novel signature to guide osteosarcoma prognosis and immune microenvironment: Cuproptosis-related lncRNA
M Yang, H Zheng, K Xu, Q Yuan, Y Aihaiti… - Frontiers in …, 2022 - frontiersin.org
Objective Osteosarcoma (OS) is a common bone malignancy with poor prognosis. We
aimed to investigate the relationship between cuproptosis-related lncRNAs (CRLncs) and …
aimed to investigate the relationship between cuproptosis-related lncRNAs (CRLncs) and …